Advertisement
BSX vs ISRG
Which Stock Would AI Choose? Boston Scientific (BSX) vs. Intuitive Surgical (ISRG) Stock Comparison
Key Takeaways
- BSX has experienced sharper recent declines, trading near 52-week lows amid guidance adjustments and operational disruptions, while ISRG shows more moderate pullbacks with resilient procedure volumes.
- Both companies operate in the medical devices sector, but BSX offers broader exposure across cardiovascular and other areas, whereas ISRG focuses primarily on robotic-assisted surgery systems.
- Recent market activity highlights BSX facing multiple headwinds including a cyberattack impact, contrasted with ISRG maintaining stronger year-over-year revenue growth despite some U.S. slowdown signals.
- Valuation metrics indicate BSX trades at lower forward multiples relative to ISRG, reflecting differing growth profiles and risk perceptions in the current environment.
- Sector sentiment remains tied to healthcare spending trends and innovation pipelines, with both stocks sensitive to macroeconomic factors affecting hospital capital expenditures.
- Relative performance over recent weeks favors ISRG in terms of price stability compared to BSX's elevated volatility.
Introduction
Boston Scientific Corporation (BSX) and Intuitive Surgical, Inc. (ISRG) represent two prominent players in the healthcare equipment space, each with distinct approaches to minimally invasive medical technologies. This comparison examines their business models, recent stock behavior, and positioning amid evolving market conditions. Investors and traders focused on the medical devices sector, particularly those evaluating growth-oriented healthcare names with varying risk exposures, may find this analysis relevant for assessing relative opportunities. The discussion draws on observable performance metrics and developments from recent market activity to provide a balanced view without forward-looking speculation.
BSX Overview and Recent Performance
Boston Scientific Corporation develops and manufactures a wide range of medical devices, including those for cardiovascular, endoscopy, and neuromodulation applications. In recent weeks, BSX stock has traded near multi-year lows following adjustments to full-year guidance and the effects of a cyberattack that temporarily disrupted operations. Market activity reflects investor focus on slower growth in certain segments such as electrophysiology and WATCHMAN, contributing to heightened volatility. Broader sector peers showed mixed results, with the stock's performance diverging from the healthcare equipment group amid these company-specific factors. Sentiment has been influenced by operational recovery updates and ongoing pipeline developments, though price action indicates caution in the near term.
ISRG Overview and Recent Performance
Intuitive Surgical, Inc. specializes in robotic-assisted surgical systems, primarily through its da Vinci platform, serving hospitals worldwide. Recent market activity for ISRG shows more contained price movements compared to broader sector swings, supported by continued procedure volume growth even as U.S. trends moderated slightly. The company reported solid revenue expansion in its most recent quarterly results, reflecting international demand strength. Stock behavior has been shaped by competitive dynamics in robotic surgery and capital spending patterns among healthcare providers. Overall sentiment remains anchored to execution on system placements and recurring instrument revenue, with the shares demonstrating relative resilience amid market fluctuations.
Trending AI Robots
Tickeron’s Trending AI Robots page showcases a curated selection of AI-powered trading bots optimized for prevailing market conditions. While Tickeron offers hundreds of AI trading bots that cover thousands of tickers across diverse strategies, timeframes, and performance profiles, only those demonstrating strong suitability for current environments appear in this trending section. Available bots exhibit varied statistics, including ranges of historical win rates, drawdowns, and return profiles depending on their specific parameters and ticker focus. This resource allows users to explore automated trading approaches tailored to individual preferences. Review the Trending AI Robots page for additional details on active options.
Head-to-Head Comparison
BSX and ISRG differ markedly in business focus: the former maintains a diversified portfolio across multiple therapeutic areas, while the latter concentrates on high-precision robotic platforms with recurring revenue from procedures. Growth drivers for BSX include broader device adoption, yet recent momentum has been tempered by segment-specific slowdowns; ISRG benefits from expanding global procedure volumes but faces increasing competition in robotics. Risk factors vary, with BSX exposed to supply chain and regulatory events and ISRG more tied to hospital capital budgets. Sector exposure overlaps in healthcare equipment, though market sentiment has recently differentiated the two based on earnings visibility and operational stability. Trade-offs center on BSX’s potentially lower valuation multiples versus ISRG’s track record of consistent innovation-driven growth.
Tickeron AI Verdict
Based on observable factors such as trend consistency and relative positioning in recent market activity, Tickeron’s AI would likely assign a probabilistic edge to ISRG due to its steadier procedure growth trajectory and lower volatility compared to BSX’s more pronounced recent challenges. This assessment reflects current data patterns rather than definitive outcomes, with both stocks subject to ongoing sector dynamics.
Disclaimer
The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.
To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BSX is a Hold and ISRG is a Buy.
| BSX | ISRG | BSX / ISRG | |
| Capitalization | 62.8B | 139B | 45% |
| EBITDA | 5.64B | 4.25B | 133% |
| Gain YTD | -54.148 | -29.082 | 186% |
| P/E Ratio | 17.55 | 45.11 | 39% |
| Revenue | 21B | 11B | 191% |
| Total Cash | 539M | 5.22B | 10% |
| Total Debt | 12.6B | 87M | 14,483% |
BSX | ISRG | ||
|---|---|---|---|
OUTLOOK RATING 1..100 | 68 | 31 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 66 Overvalued | 74 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | 86 | |
SMR RATING 1..100 | 55 | 51 | |
PRICE GROWTH RATING 1..100 | 65 | 60 | |
P/E GROWTH RATING 1..100 | 98 | 73 | |
SEASONALITY SCORE 1..100 | 65 | 50 |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
BSX's Valuation (66) in the Medical Specialties industry is in the same range as ISRG (74). This means that BSX’s stock grew similarly to ISRG’s over the last 12 months.
ISRG's Profit vs Risk Rating (86) in the Medical Specialties industry is in the same range as BSX (100). This means that ISRG’s stock grew similarly to BSX’s over the last 12 months.
ISRG's SMR Rating (51) in the Medical Specialties industry is in the same range as BSX (55). This means that ISRG’s stock grew similarly to BSX’s over the last 12 months.
ISRG's Price Growth Rating (60) in the Medical Specialties industry is in the same range as BSX (65). This means that ISRG’s stock grew similarly to BSX’s over the last 12 months.
ISRG's P/E Growth Rating (73) in the Medical Specialties industry is in the same range as BSX (98). This means that ISRG’s stock grew similarly to BSX’s over the last 12 months.
| BSX | ISRG | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 65% | 2 days ago 37% |
| Stochastic ODDS (%) | 2 days ago 64% | 2 days ago 60% |
| Momentum ODDS (%) | 2 days ago 50% | 2 days ago 71% |
| MACD ODDS (%) | 2 days ago 60% | 2 days ago 63% |
| TrendWeek ODDS (%) | 2 days ago 54% | 2 days ago 64% |
| TrendMonth ODDS (%) | 2 days ago 60% | 2 days ago 64% |
| Advances ODDS (%) | 23 days ago 59% | 2 days ago 66% |
| Declines ODDS (%) | 5 days ago 54% | 15 days ago 60% |
| BollingerBands ODDS (%) | 2 days ago 67% | 2 days ago 51% |
| Aroon ODDS (%) | 2 days ago 67% | 2 days ago 64% |
Long-Term Analysis
It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is overvalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).
BSX’s FA Score shows that 0 FA rating(s) are green while ISRG’s FA Score has 0 green FA rating(s).
- BSX’s FA Score: 0 green, 5 red.
- ISRG’s FA Score: 0 green, 5 red.
Short-Term Analysis
It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.
If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.
BSX’s TA Score shows that 4 TA indicator(s) are bullish while ISRG’s TA Score has 5 bullish TA indicator(s).
- BSX’s TA Score: 4 bullish, 6 bearish.
- ISRG’s TA Score: 5 bullish, 5 bearish.
Price Growth
BSX (@Medical/Nursing Services) experienced а -2.95% price change this week, while ISRG (@Pharmaceuticals: Other) price change was +6.27% for the same time period.
The average weekly price growth across all stocks in the @Medical/Nursing Services industry was +4.63%. For the same industry, the average monthly price growth was -6.41%, and the average quarterly price growth was +0.36%.
The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +1.80%. For the same industry, the average monthly price growth was -1.92%, and the average quarterly price growth was +17.48%.
Reported Earning Dates
BSX is expected to report earnings on Oct 28, 2026.
ISRG is expected to report earnings on Oct 20, 2026.
Industries' Descriptions
@Medical/Nursing Services (+4.63% weekly)The medical/nursing services includes companies that provide medical-related services such as ambulance services, dialysis centers, respiratory therapy, blood testing and rehabilitation services. DaVita Inc., Chemed Corporation and Guardant Health, Inc. are examples of companies in this industry.
@Pharmaceuticals: Other (+1.80% weekly)Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.
Advertisement